115 related articles for article (PubMed ID: 38723817)
1. Dihydroquercetin alleviates dopamine neuron loss via regulating TREM2 activation.
Yang R; Li DD; Li XX; Yang XX; Gao HM; Zhang F
Int J Biol Macromol; 2024 Jun; 269(Pt 2):132179. PubMed ID: 38723817
[TBL] [Abstract][Full Text] [Related]
2. TREM2 Deficiency Aggravates NLRP3 Inflammasome Activation and Pyroptosis in MPTP-Induced Parkinson's Disease Mice and LPS-Induced BV2 Cells.
Huang P; Zhang Z; Zhang P; Feng J; Xie J; Zheng Y; Liang X; Zhu B; Chen Z; Feng S; Wang L; Lu J; Liu Y; Zhang Y
Mol Neurobiol; 2024 May; 61(5):2590-2605. PubMed ID: 37917301
[TBL] [Abstract][Full Text] [Related]
3. Naringenin Produces Neuroprotection Against LPS-Induced Dopamine Neurotoxicity via the Inhibition of Microglial NLRP3 Inflammasome Activation.
Chen C; Wei YZ; He XM; Li DD; Wang GQ; Li JJ; Zhang F
Front Immunol; 2019; 10():936. PubMed ID: 31118933
[No Abstract] [Full Text] [Related]
4. Ellagic Acid Protects Dopamine Neurons via Inhibition of NLRP3 Inflammasome Activation in Microglia.
He XM; Zhou YZ; Sheng S; Li JJ; Wang GQ; Zhang F
Oxid Med Cell Longev; 2020; 2020():2963540. PubMed ID: 33294118
[TBL] [Abstract][Full Text] [Related]
5. Myricitrin Ameliorates 6-Hydroxydopamine-Induced Dopaminergic Neuronal Loss in the Substantia Nigra of Mouse Brain.
Kim HD; Jeong KH; Jung UJ; Kim SR
J Med Food; 2016 Apr; 19(4):374-82. PubMed ID: 26991235
[TBL] [Abstract][Full Text] [Related]
6. TREM2 modulates microglia phenotypes in the neuroinflammation of Parkinson's disease.
Zhang Y; Feng S; Nie K; Li Y; Gao Y; Gan R; Wang L; Li B; Sun X; Wang L; Zhang Y
Biochem Biophys Res Commun; 2018 May; 499(4):797-802. PubMed ID: 29621548
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol protects dopamine neurons against lipopolysaccharide-induced neurotoxicity through its anti-inflammatory actions.
Zhang F; Shi JS; Zhou H; Wilson B; Hong JS; Gao HM
Mol Pharmacol; 2010 Sep; 78(3):466-77. PubMed ID: 20554604
[TBL] [Abstract][Full Text] [Related]
8. Tetrahydroxystilbene Glucoside Produces Neuroprotection against 6-OHDA-Induced Dopamine Neurotoxicity.
Huang C; Lin F; Wang G; Lu D; Wu Q; Liu J; Shi J; Zhang F
Oxid Med Cell Longev; 2018; 2018():7927568. PubMed ID: 29576855
[TBL] [Abstract][Full Text] [Related]
9. Galangin Reduces the Loss of Dopaminergic Neurons in an LPS-Evoked Model of Parkinson's Disease in Rats.
Chen G; Liu J; Jiang L; Ran X; He D; Li Y; Huang B; Wang W; Fu S
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29267220
[TBL] [Abstract][Full Text] [Related]
10. Neuron-derived IgG protects dopaminergic neurons from insult by 6-OHDA and activates microglia through the FcγR I and TLR4 pathways.
Zhang J; Niu N; Wang M; McNutt MA; Zhang D; Zhang B; Lu S; Liu Y; Liu Z
Int J Biochem Cell Biol; 2013 Aug; 45(8):1911-20. PubMed ID: 23791745
[TBL] [Abstract][Full Text] [Related]
11. Clozapine metabolites protect dopaminergic neurons through inhibition of microglial NADPH oxidase.
Jiang L; Wu X; Wang S; Chen SH; Zhou H; Wilson B; Jin CY; Lu RB; Xie K; Wang Q; Hong JS
J Neuroinflammation; 2016 May; 13(1):110. PubMed ID: 27184631
[TBL] [Abstract][Full Text] [Related]
12. Squamosamide derivative FLZ protects dopaminergic neurons against inflammation-mediated neurodegeneration through the inhibition of NADPH oxidase activity.
Zhang D; Hu X; Wei SJ; Liu J; Gao H; Qian L; Wilson B; Liu G; Hong JS
J Neuroinflammation; 2008 May; 5():21. PubMed ID: 18507839
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
[TBL] [Abstract][Full Text] [Related]
14. Somatostatin prevents lipopolysaccharide-induced neurodegeneration in the rat substantia nigra by inhibiting the activation of microglia.
Bai L; Zhang X; Li X; Liu N; Lou F; Ma H; Luo X; Ren Y
Mol Med Rep; 2015 Jul; 12(1):1002-8. PubMed ID: 25777539
[TBL] [Abstract][Full Text] [Related]
15. Montelukast treatment protects nigral dopaminergic neurons against microglial activation in the 6-hydroxydopamine mouse model of Parkinson's disease.
Jang H; Kim S; Lee JM; Oh YS; Park SM; Kim SR
Neuroreport; 2017 Mar; 28(5):242-249. PubMed ID: 28178069
[TBL] [Abstract][Full Text] [Related]
16. Polydatin Prevents Lipopolysaccharide (LPS)-Induced Parkinson's Disease via Regulation of the AKT/GSK3β-Nrf2/NF-κB Signaling Axis.
Huang B; Liu J; Meng T; Li Y; He D; Ran X; Chen G; Guo W; Kan X; Fu S; Wang W; Liu D
Front Immunol; 2018; 9():2527. PubMed ID: 30455692
[TBL] [Abstract][Full Text] [Related]
17. Microglial cells are involved in the susceptibility of NADPH oxidase knockout mice to 6-hydroxy-dopamine-induced neurodegeneration.
Hernandes MS; Santos GD; Café-Mendes CC; Lima LS; Scavone C; Munhoz CD; Britto LR
PLoS One; 2013; 8(9):e75532. PubMed ID: 24086556
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effect of omega-3 polyunsaturated fatty acids in the 6-OHDA model of Parkinson's disease is mediated by a reduction of inducible nitric oxide synthase.
Mori MA; Delattre AM; Carabelli B; Pudell C; Bortolanza M; Staziaki PV; Visentainer JV; Montanher PF; Del Bel EA; Ferraz AC
Nutr Neurosci; 2018 Jun; 21(5):341-351. PubMed ID: 28221817
[TBL] [Abstract][Full Text] [Related]
19. TREM2 overexpression attenuates neuroinflammation and protects dopaminergic neurons in experimental models of Parkinson's disease.
Ren M; Guo Y; Wei X; Yan S; Qin Y; Zhang X; Jiang F; Lou H
Exp Neurol; 2018 Apr; 302():205-213. PubMed ID: 29407460
[TBL] [Abstract][Full Text] [Related]
20. Nilotinib inhibits microglia-mediated neuroinflammation to protect against dopaminergic neuronal death in Parkinson's disease models.
Wu J; Xu X; Zheng L; Mo J; Jin X; Bao Y
Int Immunopharmacol; 2021 Oct; 99():108025. PubMed ID: 34364303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]